DK2053048T3 - Fremgangsmåde til in situ kemisk sulfonering - Google Patents

Fremgangsmåde til in situ kemisk sulfonering

Info

Publication number: DK2053048T3
Authority: DK; Denmark
Prior art keywords: situ chemical; sulfonation; chemical sulfonation; situ; chemical
Prior art date: 2005-09-30

Application number

DK09152654.1T

Other languages

English (en)

Inventor

Philip John Hogan

David Michael Glanville Martin

Francis Joseph Montgomery

George Joseph Sependa

Joergen Blixt

Michael David Golden

Nicholas Cartwright Alexander Wright

Zakariya Patel

John David Pittman

Christopher John Squire

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-30

Filing date

2006-09-27

Publication date

2010-11-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35395001&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2053048(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2010-11-29 Application granted granted Critical

2010-11-29 Publication of DK2053048T3 publication Critical patent/DK2053048T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

DK09152654.1T 2005-09-30 2006-09-27 Fremgangsmåde til in situ kemisk sulfonering DK2053048T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0519879.1A GB0519879D0 (en)	2005-09-30	2005-09-30	Chemical process
EP06794582A EP1943240B1 (en)	2005-09-30	2006-09-27	Chemical process

Publications (1)

Publication Number	Publication Date
DK2053048T3 true DK2053048T3 (da)	2010-11-29

Family

ID=35395001

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK09152654.1T DK2053048T3 (da)	2005-09-30	2006-09-27	Fremgangsmåde til in situ kemisk sulfonering
DK06794582.4T DK1943240T3 (da)	2005-09-30	2006-09-27	Kemisk fremgangsmåde

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK06794582.4T DK1943240T3 (da)	2005-09-30	2006-09-27	Kemisk fremgangsmåde

Country Status (32)

Country	Link
US (8)	US8163926B2 (da)
EP (2)	EP1943240B1 (da)
JP (2)	JP5213715B2 (da)
KR (1)	KR101307641B1 (da)
CN (3)	CN102503933B (da)
AR (1)	AR055671A1 (da)
AT (2)	ATE481399T1 (da)
AU (1)	AU2006296367B2 (da)
BR (1)	BRPI0616715A2 (da)
CA (2)	CA2624045C (da)
CY (2)	CY1110275T1 (da)
DE (2)	DE602006010428D1 (da)
DK (2)	DK2053048T3 (da)
ES (2)	ES2335435T3 (da)
GB (1)	GB0519879D0 (da)
HK (2)	HK1122553A1 (da)
HR (2)	HRP20100019T1 (da)
IL (2)	IL190172A (da)
ME (2)	ME01466B (da)
MY (2)	MY145540A (da)
NO (1)	NO342152B1 (da)
NZ (2)	NZ566566A (da)
PL (2)	PL1943240T3 (da)
PT (2)	PT2053048E (da)
RS (2)	RS51515B (da)
RU (1)	RU2448102C2 (da)
SG (1)	SG165416A1 (da)
SI (2)	SI2053048T1 (da)
TW (2)	TWI424991B (da)
UY (1)	UY29824A1 (da)
WO (1)	WO2007036713A2 (da)
ZA (1)	ZA200802416B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA81619C2 (ru) *	2002-02-01	2008-01-25	Астразенека Аб	Хиназолиновые соединения, способ их получения (варианты), фармацевтическая композиция на их основе
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
US7851623B2 (en) *	2006-11-02	2010-12-14	Astrazeneca Ab	Chemical process
EP2404595B1 (de) *	2011-09-01	2015-08-05	Symrise AG	Verfahren zur Herstellung von Indanon-Derivaten
CN107163038B (zh) *	2012-08-15	2020-07-28	葛兰素集团有限公司	化学方法
CN104098544A (zh) *	2013-04-07	2014-10-15	浙江九洲药物科技有限公司	一种凡德他尼的制备方法
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4870083A (en) *	1987-11-24	1989-09-26	Merrell Dow Pharmaceuticals Inc.	1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants
JP2829744B2 (ja)	1989-05-31	1998-12-02	川研ファインケミカル株式会社	ピペリジンカルボン酸類の製造方法
AU8506791A (en)	1990-10-01	1992-04-28	Janssen Pharmaceutica N.V.	Novel 4-piperidinylcarbonyl derivatives
ES2188584T3 (es)	1991-03-28	2003-07-01	Eisai Co Ltd	Derivados heterociclicos de amina.
AU658646B2 (en)	1991-05-10	1995-04-27	Rhone-Poulenc Rorer International (Holdings) Inc.	Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
CA2118117A1 (en)	1993-02-18	1994-08-19	Shigeki Fujiwara	Adenosine uptake inhibitor
NZ267296A (en)	1993-05-26	1997-04-24	Syntex Inc	4-(aminophenyl) omega amino- or 4-piperidyl- alkyl ketone derivatives; pharmaceutical compositions
DE4326344A1 (de)	1993-08-05	1995-02-09	Thomae Gmbh Dr K	Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CA2180746A1 (en) *	1994-01-13	1995-07-20	Raymond Baker	Gem-disubstituted azacyclic tachykinin antagonists
GB9624482D0 (en) *	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
EP0885198B1 (en)	1996-03-05	2001-12-19	AstraZeneca AB	4-anilinoquinazoline derivatives
WO1998010767A2 (en)	1996-09-13	1998-03-19	Sugen, Inc.	Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
ES2306306T3 (es) *	1999-11-05	2008-11-01	Astrazeneca Ab	Nuevos derivados de quinazolina.
GB0126879D0 (en)	2001-11-08	2002-01-02	Astrazeneca Ab	Combination therapy
AU2002366801B8 (en)	2001-12-20	2009-05-21	Osi Pharmaceuticals, Inc.	Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
UA81619C2 (ru)	2002-02-01	2008-01-25	Астразенека Аб	Хиназолиновые соединения, способ их получения (варианты), фармацевтическая композиция на их основе
AU2003207291A1 (en)	2002-02-06	2003-09-02	Ube Industries, Ltd.	Process for producing 4-aminoquinazoline compound
WO2004014383A1 (en)	2002-08-09	2004-02-19	Astrazeneca Ab	Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
GB0218526D0 (en)	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en)	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
CA2514227C (en)	2003-02-13	2011-08-09	Astrazeneca Ab	Combination therapy of zd6474 with 5-fu or/and cpt-11
KR20120093411A (ko)	2003-07-10	2012-08-22	아스트라제네카 아베	백금 화합물 및 임의적으로 이온화 방사능과 조합된 퀴나졸린 유도체 ｚｄ6474의 혈관신생 및/또는 증가된 혈관 투과성 관련 질환 치료 용도
GB0318423D0 (en)	2003-08-06	2003-09-10	Astrazeneca Ab	Chemical compounds
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process

2005
- 2005-09-30 GB GBGB0519879.1A patent/GB0519879D0/en not_active Ceased
2006
- 2006-09-27 NZ NZ566566A patent/NZ566566A/en not_active IP Right Cessation
- 2006-09-27 CN CN201110159628.2A patent/CN102503933B/zh active Active
- 2006-09-27 ES ES06794582T patent/ES2335435T3/es active Active
- 2006-09-27 EP EP06794582A patent/EP1943240B1/en active Active
- 2006-09-27 KR KR1020087009317A patent/KR101307641B1/ko active IP Right Grant
- 2006-09-27 PT PT09152654T patent/PT2053048E/pt unknown
- 2006-09-27 ME MEP-2013-21A patent/ME01466B/me unknown
- 2006-09-27 PL PL06794582T patent/PL1943240T3/pl unknown
- 2006-09-27 BR BRPI0616715-2A patent/BRPI0616715A2/pt not_active IP Right Cessation
- 2006-09-27 DE DE602006010428T patent/DE602006010428D1/de active Active
- 2006-09-27 AT AT09152654T patent/ATE481399T1/de active
- 2006-09-27 AU AU2006296367A patent/AU2006296367B2/en not_active Ceased
- 2006-09-27 JP JP2008532864A patent/JP5213715B2/ja not_active Expired - Fee Related
- 2006-09-27 ES ES09152654T patent/ES2350513T3/es active Active
- 2006-09-27 EP EP09152654A patent/EP2053048B8/en active Active
- 2006-09-27 DE DE602006017004T patent/DE602006017004D1/de active Active
- 2006-09-27 CN CN201110159729.XA patent/CN102503898B/zh active Active
- 2006-09-27 ME MEP-2013-51A patent/ME01531B/me unknown
- 2006-09-27 SG SG201006940-9A patent/SG165416A1/en unknown
- 2006-09-27 DK DK09152654.1T patent/DK2053048T3/da active
- 2006-09-27 CA CA2624045A patent/CA2624045C/en not_active Expired - Fee Related
- 2006-09-27 MY MYPI20080855A patent/MY145540A/en unknown
- 2006-09-27 WO PCT/GB2006/003587 patent/WO2007036713A2/en active Application Filing
- 2006-09-27 MY MYPI2011003076A patent/MY149834A/en unknown
- 2006-09-27 SI SI200630816T patent/SI2053048T1/sl unknown
- 2006-09-27 CN CN200680036468XA patent/CN101277948B/zh active Active
- 2006-09-27 DK DK06794582.4T patent/DK1943240T3/da active
- 2006-09-27 PT PT06794582T patent/PT1943240E/pt unknown
- 2006-09-27 CA CA2745829A patent/CA2745829C/en not_active Expired - Fee Related
- 2006-09-27 US US12/088,680 patent/US8163926B2/en active Active
- 2006-09-27 SI SI200630524T patent/SI1943240T1/sl unknown
- 2006-09-27 PL PL09152654T patent/PL2053048T3/pl unknown
- 2006-09-27 RS RSP-2010/0520A patent/RS51515B/en unknown
- 2006-09-27 RS RSP-2010/0037A patent/RS51263B/sr unknown
- 2006-09-27 RU RU2008116573/04A patent/RU2448102C2/ru not_active IP Right Cessation
- 2006-09-27 NZ NZ593930A patent/NZ593930A/xx not_active IP Right Cessation
- 2006-09-27 AT AT06794582T patent/ATE448218T1/de active
- 2006-09-29 AR ARP060104320A patent/AR055671A1/es not_active Application Discontinuation
- 2006-09-29 UY UY29824A patent/UY29824A1/es unknown
- 2006-09-29 TW TW099102690A patent/TWI424991B/zh not_active IP Right Cessation
- 2006-09-29 TW TW095136340A patent/TWI328580B/zh not_active IP Right Cessation
2008
- 2008-03-11 NO NO20081267A patent/NO342152B1/no not_active IP Right Cessation
- 2008-03-13 IL IL190172A patent/IL190172A/en not_active IP Right Cessation
- 2008-03-14 ZA ZA200802416A patent/ZA200802416B/xx unknown
- 2008-12-15 HK HK08113582.9A patent/HK1122553A1/xx not_active IP Right Cessation
2009
- 2009-09-21 HK HK09108619.5A patent/HK1130478A1/xx not_active IP Right Cessation
2010
- 2010-01-11 HR HR20100019T patent/HRP20100019T1/hr unknown
- 2010-01-25 CY CY20101100076T patent/CY1110275T1/el unknown
- 2010-11-12 CY CY20101101019T patent/CY1110887T1/el unknown
- 2010-11-16 HR HR20100620T patent/HRP20100620T1/hr unknown
2011
- 2011-12-07 US US13/314,034 patent/US8865899B2/en active Active
2012
- 2012-11-28 JP JP2012259782A patent/JP5654546B2/ja not_active Expired - Fee Related
2013
- 2013-07-21 IL IL227574A patent/IL227574A/en not_active IP Right Cessation
2014
- 2014-09-09 US US14/481,302 patent/US20140378684A1/en not_active Abandoned
2015
- 2015-07-22 US US14/805,816 patent/US9815816B2/en active Active
2017
- 2017-10-27 US US15/796,615 patent/US10344015B2/en active Active
2019
- 2019-05-08 US US16/406,246 patent/US20190263782A1/en not_active Abandoned
2020
- 2020-11-02 US US17/086,666 patent/US20220033377A1/en not_active Abandoned
2023
- 2023-03-07 US US18/118,549 patent/US20240150317A1/en active Pending

Also Published As

Publication number	Publication date
TWI424991B (zh)	2014-02-01
RS51515B (en)	2011-06-30
NZ593930A (en)	2013-02-22
CN102503933B (zh)	2014-06-25
TW200745036A (en)	2007-12-16
TW201018660A (en)	2010-05-16
US9815816B2 (en)	2017-11-14
CA2745829A1 (en)	2007-04-05
IL190172A0 (en)	2008-08-07
CN101277948A (zh)	2008-10-01
CA2624045C (en)	2012-05-22
HRP20100620T1 (hr)	2010-12-31
US8865899B2 (en)	2014-10-21
US20140378684A1 (en)	2014-12-25
HK1130478A1 (en)	2009-12-31
IL190172A (en)	2014-05-28
AU2006296367B2 (en)	2011-08-11
CY1110887T1 (el)	2015-06-10
CN101277948B (zh)	2013-03-13
ME01466B (me)	2014-04-20
JP2009510039A (ja)	2009-03-12
CA2745829C (en)	2013-07-02
DE602006010428D1 (de)	2009-12-24
EP2053048A1 (en)	2009-04-29
RU2448102C2 (ru)	2012-04-20
RU2008116573A (ru)	2009-11-10
KR20080049114A (ko)	2008-06-03
SG165416A1 (en)	2010-10-28
CN102503933A (zh)	2012-06-20
EP1943240B1 (en)	2009-11-11
GB0519879D0 (en)	2005-11-09
HRP20100019T1 (hr)	2010-02-28
AR055671A1 (es)	2007-08-29
CN102503898B (zh)	2015-03-25
US20240150317A1 (en)	2024-05-09
CY1110275T1 (el)	2015-01-14
CA2624045A1 (en)	2007-04-05
WO2007036713A3 (en)	2007-06-14
US20180118716A1 (en)	2018-05-03
HK1122553A1 (en)	2009-05-22
ME01531B (me)	2014-04-20
RS51263B (sr)	2010-12-31
US20190263782A1 (en)	2019-08-29
EP2053048B8 (en)	2011-09-21
WO2007036713A2 (en)	2007-04-05
ATE448218T1 (de)	2009-11-15
BRPI0616715A2 (pt)	2011-06-28
PL1943240T3 (pl)	2010-04-30
KR101307641B1 (ko)	2013-09-12
CN102503898A (zh)	2012-06-20
ZA200802416B (en)	2009-01-28
ES2350513T3 (es)	2011-01-24
EP2053048B1 (en)	2010-09-15
US20220033377A1 (en)	2022-02-03
JP2013063998A (ja)	2013-04-11
SI2053048T1 (sl)	2010-12-31
US20090203905A1 (en)	2009-08-13
JP5213715B2 (ja)	2013-06-19
ATE481399T1 (de)	2010-10-15
NO342152B1 (no)	2018-04-03
MY149834A (en)	2013-10-31
US10344015B2 (en)	2019-07-09
DE602006017004D1 (de)	2010-10-28
PT2053048E (pt)	2010-11-10
US8163926B2 (en)	2012-04-24
EP1943240A2 (en)	2008-07-16
AU2006296367A1 (en)	2007-04-05
IL227574A (en)	2015-08-31
NO20081267L (no)	2008-04-30
ES2335435T3 (es)	2010-03-26
US20120095229A1 (en)	2012-04-19
DK1943240T3 (da)	2010-03-01
PT1943240E (pt)	2010-01-11
US20160185754A1 (en)	2016-06-30
NZ566566A (en)	2011-08-26
MY145540A (en)	2012-02-29
TWI328580B (en)	2010-08-11
JP5654546B2 (ja)	2015-01-14
PL2053048T3 (pl)	2011-03-31
SI1943240T1 (sl)	2010-02-26
UY29824A1 (es)	2007-04-30

Publication	Publication Date	Title
DK1803001T3 (da)	2012-05-29	Fremgangsmåde til overvågning af carbonhydrid-beholder
ATE510643T1 (de)	2011-06-15	Werkzeugaufbau
DK1704797T3 (da)	2011-11-21	Arbejdsbord
DE602006010131D1 (de)	2009-12-17	Elektrochemische Vorrichtung
DE502006001178D1 (de)	2008-09-04	Pipettiervorrichtung
DK1880781T3 (da)	2011-06-20	Fremgangsmåde til kasseløs formning
DE502005005547D1 (de)	2008-11-13	Pipettiervorrichtung
DE602006012689D1 (de)	2010-04-15	Überprüfungsverfahren
DK2053048T3 (da)	2010-11-29	Fremgangsmåde til in situ kemisk sulfonering
DE602006001668D1 (de)	2008-08-21	Fehlerüberprüfungsverfahren
DE502006008367D1 (de)	2011-01-05	Pipettiervorrichtung
FI20050708A (fi)	2007-01-02	Menetelmä polystyreenin kierrättämiseksi
DK2069093T3 (da)	2016-01-11	Nedholder til pladesakse
DE602006021285D1 (de)	2011-05-26	Mikrotomklinge
FI20050681A (fi)	2006-12-23	Paikoitusmenetelmä
ES1059333Y (es)	2005-07-16	Protector-expositor removible para pilares
NO20055841D0 (no)	2005-12-08	Kjemiske forbindelser
IS2409B (is)	2008-10-15	Búnaður til þess að skera niður
NO20054981D0 (no)	2005-10-26	Dreieanordning til mobel
DK1934388T3 (da)	2013-02-25	Fremgangsmåde til lægemiddeludvikling
FI20050298A0 (fi)	2005-03-21	Menetelmä protrombiiniajan määrittämiseksi
DE502006005025D1 (de)	2009-11-19	Werkzeug
DE602005022946D1 (de)	2010-09-23	Strukturierungsverfahren
TH110856B (th)	2011-11-21	กรรมวิธีเชิงเคมี
FI20055471A0 (fi)	2005-09-05	Menetelmä pohjarakentamisessa